Australians over 50 can get their AstraZeneca vaccine from a GP clinic from today. Here's what you need to know when you book yourself in.
Academic rigor, journalistic flair
Articles on Aspirin
Displaying 1 - 20 of 21 articles
Every time you pop an aspirin, thank the German chemist Hoffmann and not Hippocrates.
It’s early days yet but a growing body of research evidence suggests COVID-19 causes abnormalities in blood clotting, which means blood thinning drugs may have a role to play in treatment.
Evidence now shows that for the majority of healthy people, the risks of bleeding with a daily Aspirin outweigh any heart benefits. How long will it take for your doctor to tell you?
Research shows that Aspirin could reduce the number of HIV infections in women at high risk for HIV, such as Kenyan female sex workers.
Taking low-dose aspirin daily doesn’t delay the onset of disability in healthy older people. Nor does it prevent heart attack or stroke in those who hadn’t experienced either condition before.
They’re often no more effective than placebo, but that shouldn’t necessarily stop us using them.
Trials into the effectiveness of drugs and treatments struggle to recruit enough participants, yet we rely on their results anyway.
What makes aspirin different to other NSAIDs, used to relieve pain, is its ability to thin the blood. It is used to prevent blood clotting in those at risk of heart disease and stroke.
Some people are incapable of swallowing tablets because of physical or psychological reasons. What should they do when the doctor prescribes a drug that comes in tablet form?
Aspirin reduces cancer risk in overweight people with an inherited condition, but the findings could be relevant to the rest of us too.
Common over-the-counter painkillers, such as ibuprofen and aspirin, can decrease risk of developing squamous cell carcinoma, according to a study published today in the Journal of Investigative Dermatology…
Cancer is a disease of genes. DNA mutations mess with the genetic content of a cell, enabling it to escape the normal controls that restrict their growth. Now, a team of scientists led by Delphine Lissa…
Taking aspirin before going to bed may reduce the risk of having a heart attack in the morning. A new study has shown the…
Women who use aspirin for five or more years have a 30% lower risk of developing melanoma skin cancer than women who don’t take aspirin, a new study has found. Previous studies have linked aspirin with…
Long term aspirin users may be at a higher risk of developing age-related macular degeneration, which can cause blindness in old age, a new study has found. The study, led by the University of Sydney and…
Stroke patients resistant to the anti-platelet effects of aspirin are more likely to have severe strokes. A study found 29…
The humble aspirin has a remarkable history dating back to ancient Egyptian times when the bark of weeping willow (which contains salicin from which the aspirin formulation is derived) was found to have…
Aspirin is a historical marvel. It’s been manufactured for more than a century and is still in widespread use. No other medication can claim as many different narratives and uses as this analgesic – it’s…
Common household drugs such as aspirin help to contain certain types of tumours by tightening their lymphatic vessel supply lines, new research has found. Doctors have long observed the impact of non-steroidal…
Top contributors
-
Professor and Head, Cardiovascular Research Unit, Monash University
-
Professor, Head of School of Public Health & Preventive Medicine, Monash University
-
Professorial Research Fellow. School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Associate Professor in Pharmacology, Murdoch University
-
Specialist General Practitioner, and Conjoint Senior Lecturer, UNSW
-
Emeritus Professor of Medicine, Monash University
-
Interventional Cardiologist, Alfred Hospital; Professor of Medicine and Immunology, Monash University; Professor and Head, Department of Cardiometabolic Health, University of Melbourne; Lab Head, Atherothrombosis and Vascular Biology and Deputy Director, Baker Heart and Diabetes Institute
-
Professor of Epidemiology & Preventative Medicine, Monash University
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Researcher, L’Université d’Ottawa/University of Ottawa
-
Senior Research Officer, QIMR Berghofer Medical Research Institute
-
Clinical Senior Lecturer in Dermatology, Australian National University
-
Professor of Clinical Genetics, Newcastle University
-
Pre-doctoral researcher, University of Aberdeen
-
Professor of Health Services Research, University of Aberdeen
